Century Therapeutics (IPSC) Total Debt (2020 - 2026)

Century Therapeutics (IPSC) has 6 years of Total Debt data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Total Debt changed N/A year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.8 million, changed N/A from the prior year.
• Total Debt for Q1 2026 stood at $1.9 million, down from $3.8 million in the prior quarter.
• Over the last five years, Total Debt for IPSC reached as high as $10.3 million in Q1 2023 and fell as low as $1.9 million in Q1 2026.
• Historically, Total Debt has averaged $8.1 million across 4 years, with a median of $10.1 million in 2022.
• Across the five-year window, Total Debt rose 3.01% in 2022 and rose 2.78% in 2023, its largest moves.
• Year by year, Total Debt stood at $10.2 million in 2022, then advanced by 0.55% to $10.3 million in 2023, then plunged by 63.51% to $3.8 million in 2025, then slumped by 48.39% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $8.3 million in Q3 2025.